These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32939993)

  • 1. The tumour immune landscape and its implications in cutaneous melanoma.
    Attrill GH; Ferguson PM; Palendira U; Long GV; Wilmott JS; Scolyer RA
    Pigment Cell Melanoma Res; 2021 May; 34(3):529-549. PubMed ID: 32939993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy.
    Lee N; Zakka LR; Mihm MC; Schatton T
    Pathology; 2016 Feb; 48(2):177-87. PubMed ID: 27020390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
    Jacobs JF; Nierkens S; Figdor CG; de Vries IJ; Adema GJ
    Lancet Oncol; 2012 Jan; 13(1):e32-42. PubMed ID: 22225723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma tumour-infiltrating T-lymphocyte therapy heralds the era of cell-based immunotherapies for solid tumours.
    Talty R; Richmond R; Micevic G
    Br J Dermatol; 2024 May; 190(6):779-781. PubMed ID: 38516835
    [No Abstract]   [Full Text] [Related]  

  • 5. Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
    Vilgelm AE; Johnson CA; Prasad N; Yang J; Chen SC; Ayers GD; Pawlikowski JS; Raman D; Sosman JA; Kelley M; Ecsedy JA; Shyr Y; Levy SE; Richmond A
    J Natl Cancer Inst; 2016 Jun; 108(6):djv406. PubMed ID: 26719346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.
    Schatton T; Scolyer RA; Thompson JF; Mihm MC
    Methods Mol Biol; 2014; 1102():287-324. PubMed ID: 24258985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression in cutaneous melanoma: histological assessment, immune mechanisms and clinical implications.
    Aivazian K
    Pathology; 2023 Mar; 55(2):227-235. PubMed ID: 36639333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response.
    Carey AE; Weeraratna AT
    Pharmacol Ther; 2024 Oct; 262():108698. PubMed ID: 39098769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis.
    Huang L; Chen H; Xu Y; Chen J; Liu Z; Xu Q
    Cancer Med; 2020 Nov; 9(22):8444-8456. PubMed ID: 32931642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
    Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
    Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma.
    Aarntzen EH; Bol K; Schreibelt G; Jacobs JF; Lesterhuis WJ; Van Rossum MM; Adema GJ; Figdor CG; Punt CJ; De Vries IJ
    Cancer Res; 2012 Dec; 72(23):6102-10. PubMed ID: 23010076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization Cancer Immunotherapy for Melanoma.
    Vesely MD; Chen L
    J Invest Dermatol; 2020 Jun; 140(6):1134-1142. PubMed ID: 32092349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for advanced melanoma: Current knowledge and future directions.
    Nakamura K; Okuyama R
    J Dermatol Sci; 2016 Aug; 83(2):87-94. PubMed ID: 27302423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and Phenotypic Characterization of Tumor-Infiltrating NK Cells in Skin Carcinoma.
    Arjmand B; Hamidpour SK; Tayanloo-Beik A; Arjmand R; Rezaei-Tavirani M; Aghayan H; Rajaeinejad M; Larijani B
    Methods Mol Biol; 2024; 2849():215-226. PubMed ID: 38329617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immunology of Melanoma.
    Ko JS
    Clin Lab Med; 2017 Sep; 37(3):449-471. PubMed ID: 28802495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing.
    Bosisio FM; Antoranz A; van Herck Y; Bolognesi MM; Marcelis L; Chinello C; Wouters J; Magni F; Alexopoulos L; Stas M; Boecxstaens V; Bechter O; Cattoretti G; van den Oord J
    Elife; 2020 Feb; 9():. PubMed ID: 32057296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterisation of immune cells associated with histological regression in cutaneous melanoma.
    Osella-Abate S; Conti L; Annaratone L; Senetta R; Bertero L; Licciardello M; Caliendo V; Picciotto F; Quaglino P; Cassoni P; Ribero S
    Pathology; 2019 Aug; 51(5):487-493. PubMed ID: 31266597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principles of adoptive cell therapy based on "Tumor Infiltrating Lymphocytes"].
    Martins F; Orcurto A; Michielin O; Coukos G
    Rev Med Suisse; 2016 May; 12(519):989-93. PubMed ID: 27424426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.